Feeds › Ownership stakes (13D / 13G)
Ownership stakes (13D / 13G)
Investors who own more than 5% of a company, from activists (13D) to passive holders (13G).
About this data
- What it is
- An investor who owns more than 5% of a public company must say so. Investors who may try to influence the company, such as activists, file the longer Schedule 13D; passive holders file the shorter Schedule 13G.
- Who files it
- The investor, within days of crossing 5%, and again whenever the stake changes materially.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- 13G filings are far more common than 13D. A 13D usually means the investor intends to push for changes, so it tends to get more attention.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Filings per day, last 30 days
13D (activist) 13G (passive)
Latest ownership filings
Showing: ticker ELOX
| Filed | ScheduleBoth report a stake of more than 5%. A 13D is filed by investors who may try to influence the company, such as activists; a 13G by passive holders. | Company | Investor | Shares | % of shares | Filing |
|---|---|---|---|---|---|---|
| Nov 13, 2026 | SCHEDULE 13G/A (amended) | ELOX Eloxx Pharmaceuticals, Inc. | Matthew D. Perry | 422,716 | 10.0% | SCHEDULE 13G/A ↗ |
| Nov 13, 2026 | SCHEDULE 13G/A (amended) | ELOX Eloxx Pharmaceuticals, Inc. | Coastlands Capital LLC | 422,716 | 10.0% | SCHEDULE 13G/A ↗ |
| Nov 13, 2026 | SCHEDULE 13G/A (amended) | ELOX Eloxx Pharmaceuticals, Inc. | Coastlands Capital GP LLC | 422,716 | 10.0% | SCHEDULE 13G/A ↗ |
| Nov 13, 2026 | SCHEDULE 13G/A (amended) | ELOX Eloxx Pharmaceuticals, Inc. | Coastlands Capital Partners LP | 422,716 | 10.0% | SCHEDULE 13G/A ↗ |
| Nov 13, 2026 | SCHEDULE 13G/A (amended) | ELOX Eloxx Pharmaceuticals, Inc. | Coastlands Capital LP | 422,716 | 10.0% | SCHEDULE 13G/A ↗ |
| Aug 14, 2026 | SCHEDULE 13G | ELOX Eloxx Pharmaceuticals, Inc. | Srinivas Akkaraju | 403,586 | 9.9% | SCHEDULE 13G ↗ |
| Aug 14, 2026 | SCHEDULE 13G | ELOX Eloxx Pharmaceuticals, Inc. | Samsara Opportunity Fund GP, LLC | 201,793 | 5.0% | SCHEDULE 13G ↗ |
| Aug 14, 2026 | SCHEDULE 13G | ELOX Eloxx Pharmaceuticals, Inc. | Samsara Opportunity Fund, L.P. | 201,793 | 5.0% | SCHEDULE 13G ↗ |
| Aug 14, 2026 | SCHEDULE 13G | ELOX Eloxx Pharmaceuticals, Inc. | Samsara BioCapital GP, LLC | 201,793 | 5.0% | SCHEDULE 13G ↗ |
| Aug 14, 2026 | SCHEDULE 13G | ELOX Eloxx Pharmaceuticals, Inc. | Samsara BioCapital, L.P. | 201,793 | 5.0% | SCHEDULE 13G ↗ |
| Aug 14, 2026 | SCHEDULE 13G | ELOX Eloxx Pharmaceuticals, Inc. | Daniel Mack | 400,000 | 9.9% | SCHEDULE 13G ↗ |
| Aug 14, 2026 | SCHEDULE 13G | ELOX Eloxx Pharmaceuticals, Inc. | Wilmot B. Harkey | 400,000 | 9.9% | SCHEDULE 13G ↗ |
| Aug 14, 2026 | SCHEDULE 13G | ELOX Eloxx Pharmaceuticals, Inc. | Nantahala Capital Management, LLC | 400,000 | 9.9% | SCHEDULE 13G ↗ |
| Jul 27, 2026 | SCHEDULE 13G | ELOX Eloxx Pharmaceuticals, Inc. | abrdn Inc. | 400,000 | 9.9% | SCHEDULE 13G ↗ |
| Jul 27, 2026 | SCHEDULE 13G | ELOX Eloxx Pharmaceuticals, Inc. | Aberdeen Group plc | 400,000 | 9.9% | SCHEDULE 13G ↗ |
| Jun 17, 2026 | SCHEDULE 13G | ELOX Eloxx Pharmaceuticals, Inc. | Matthew D. Perry | 410,530 | 10.0% | SCHEDULE 13G ↗ |
| Jun 17, 2026 | SCHEDULE 13G | ELOX Eloxx Pharmaceuticals, Inc. | Coastlands Capital LLC | 410,530 | 10.0% | SCHEDULE 13G ↗ |
| Jun 17, 2026 | SCHEDULE 13G | ELOX Eloxx Pharmaceuticals, Inc. | Coastlands Capital GP LLC | 410,530 | 10.0% | SCHEDULE 13G ↗ |
| Jun 17, 2026 | SCHEDULE 13G | ELOX Eloxx Pharmaceuticals, Inc. | Coastlands Capital Partners LP | 410,530 | 10.0% | SCHEDULE 13G ↗ |
| Jun 17, 2026 | SCHEDULE 13G | ELOX Eloxx Pharmaceuticals, Inc. | Coastlands Capital LP | 410,530 | 10.0% | SCHEDULE 13G ↗ |
| Jun 17, 2026 | SCHEDULE 13G | ELOX Eloxx Pharmaceuticals, Inc. | Daniel Simon | 854,973 | 20.0% | SCHEDULE 13G ↗ |
| Jun 17, 2026 | SCHEDULE 13G | ELOX Eloxx Pharmaceuticals, Inc. | Bold Stroke Investments, LLC | 240,688 | 5.6% | SCHEDULE 13G ↗ |
| Jun 17, 2026 | SCHEDULE 13G | ELOX Eloxx Pharmaceuticals, Inc. | MSEK Charleston LLC | 240,688 | 5.6% | SCHEDULE 13G ↗ |
| Jun 17, 2026 | SCHEDULE 13G | ELOX Eloxx Pharmaceuticals, Inc. | Bkjlagg, LLC | 602,266 | 14.1% | SCHEDULE 13G ↗ |
| Jun 17, 2026 | SCHEDULE 13G | ELOX Eloxx Pharmaceuticals, Inc. | Domicilium Real Estate Fund III GP LLC | 238,422 | 5.9% | SCHEDULE 13G ↗ |
| Jun 17, 2026 | SCHEDULE 13G | ELOX Eloxx Pharmaceuticals, Inc. | Domicilium Real Estate Fund III LP | 238,422 | 5.9% | SCHEDULE 13G ↗ |
| Jun 17, 2026 | SCHEDULE 13G | ELOX Eloxx Pharmaceuticals, Inc. | Domicilium Capital Partners LLC | 854,973 | 20.0% | SCHEDULE 13G ↗ |
| Jun 16, 2026 | SCHEDULE 13G | ELOX Eloxx Pharmaceuticals, Inc. | Jon M. Plexico | 403,228 | 9.9% | SCHEDULE 13G ↗ |
| Jun 16, 2026 | SCHEDULE 13G | ELOX Eloxx Pharmaceuticals, Inc. | Stonepine GP, LLC | 403,228 | 9.9% | SCHEDULE 13G ↗ |
| Jun 16, 2026 | SCHEDULE 13G | ELOX Eloxx Pharmaceuticals, Inc. | Stonepine Capital, L.P. | 403,228 | 9.9% | SCHEDULE 13G ↗ |
| Jun 16, 2026 | SCHEDULE 13G | ELOX Eloxx Pharmaceuticals, Inc. | Stonepine Capital Management, LLC | 403,228 | 9.9% | SCHEDULE 13G ↗ |
| Jun 16, 2026 | SCHEDULE 13G | ELOX Eloxx Pharmaceuticals, Inc. | EcoR1 Capital Fund Qualified, L.P. | 377,635 | 9.3% | SCHEDULE 13G ↗ |
| Jun 16, 2026 | SCHEDULE 13G | ELOX Eloxx Pharmaceuticals, Inc. | Oleg Nodelman | 403,586 | 9.9% | SCHEDULE 13G ↗ |
| Jun 16, 2026 | SCHEDULE 13G | ELOX Eloxx Pharmaceuticals, Inc. | EcoR1 Capital, LLC | 403,586 | 9.9% | SCHEDULE 13G ↗ |
| Jun 15, 2026 | SCHEDULE 13G | ELOX Eloxx Pharmaceuticals, Inc. | Raymond Debbane | 403,586 | 10.0% | SCHEDULE 13G ↗ |
| Jun 15, 2026 | SCHEDULE 13G | ELOX Eloxx Pharmaceuticals, Inc. | Ulys, L.L.C. | 49,919 | 1.2% | SCHEDULE 13G ↗ |
| Jun 15, 2026 | SCHEDULE 13G | ELOX Eloxx Pharmaceuticals, Inc. | Avicenna Life Sci Master GP LLC | 49,919 | 1.2% | SCHEDULE 13G ↗ |
| Jun 15, 2026 | SCHEDULE 13G | ELOX Eloxx Pharmaceuticals, Inc. | Avicenna Life Sci Master Fund LP | 49,919 | 1.2% | SCHEDULE 13G ↗ |
| Jun 15, 2026 | SCHEDULE 13G | ELOX Eloxx Pharmaceuticals, Inc. | Siren, L.L.C. | 353,667 | 8.8% | SCHEDULE 13G ↗ |
| Jun 15, 2026 | SCHEDULE 13G | ELOX Eloxx Pharmaceuticals, Inc. | Invus Global Management, LLC | 353,667 | 8.8% | SCHEDULE 13G ↗ |
| Jun 15, 2026 | SCHEDULE 13G | ELOX Eloxx Pharmaceuticals, Inc. | Invus Public Equities Advisors, LLC | 353,667 | 8.8% | SCHEDULE 13G ↗ |
| Jun 15, 2026 | SCHEDULE 13G | ELOX Eloxx Pharmaceuticals, Inc. | Invus Public Equities, L.P. | 353,667 | 8.8% | SCHEDULE 13G ↗ |
| Jun 5, 2026 | SCHEDULE 13G/A (amended) | ELOX Eloxx Pharmaceuticals, Inc. | Daniel Simon | 23,478 | 4.9% | SCHEDULE 13G/A ↗ |
| Jun 5, 2026 | SCHEDULE 13G/A (amended) | ELOX Eloxx Pharmaceuticals, Inc. | Domicilium Capital Partners LLC | 23,478 | 4.9% | SCHEDULE 13G/A ↗ |
| Jun 5, 2026 | SCHEDULE 13G/A (amended) | ELOX Eloxx Pharmaceuticals, Inc. | Domicilium Real Estate Fund III GP LLC | 9,193 | 2.0% | SCHEDULE 13G/A ↗ |
| Jun 5, 2026 | SCHEDULE 13G/A (amended) | ELOX Eloxx Pharmaceuticals, Inc. | Domicilium Real Estate Fund III LP | 9,193 | 2.0% | SCHEDULE 13G/A ↗ |
| May 29, 2026 | SCHEDULE 13G/A (amended) | ELOX Eloxx Pharmaceuticals, Inc. | Matthew D. Perry | 266,539 | 5.0% | SCHEDULE 13G/A ↗ |
| May 29, 2026 | SCHEDULE 13G/A (amended) | ELOX Eloxx Pharmaceuticals, Inc. | Coastlands Capital LLC | 266,539 | 5.0% | SCHEDULE 13G/A ↗ |
| May 29, 2026 | SCHEDULE 13G/A (amended) | ELOX Eloxx Pharmaceuticals, Inc. | Coastlands Capital GP LLC | 266,539 | 5.0% | SCHEDULE 13G/A ↗ |
| May 29, 2026 | SCHEDULE 13G/A (amended) | ELOX Eloxx Pharmaceuticals, Inc. | Coastlands Capital Partners LP | 266,539 | 5.0% | SCHEDULE 13G/A ↗ |
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 7:27 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances